Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Change In Receivables : E£-291 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Receivables?

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's change in receivables for the quarter that ended in Mar. 2024 was E£-6 Mil. It means Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Accounts Receivable increased by E£6 Mil from Dec. 2023 to Mar. 2024 .

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's change in receivables for the fiscal year that ended in Dec. 2023 was E£-375 Mil. It means Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Accounts Receivable increased by E£375 Mil from Dec. 2022 to Dec. 2023 .

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Accounts Receivable for the quarter that ended in Mar. 2024 was E£448 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Days Sales Outstanding for the three months ended in Mar. 2024 was 89.68.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's liquidation value for the three months ended in Mar. 2024 was E£-651 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Receivables Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Receivables Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-134.38

-135.89

-29.45

-244.93

-374.86

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-89.89	-93.24	-167.13	-24.60	-5.91

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£-291 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	448.375	/	456.233	*	91
=	89.68

2. In Ben Graham's calculation of liquidation value, Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's accounts receivable are only considered to be worth 75% of book value:

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	342.652	-	1525.843	+	0.75 * 448.375	+	0.5 * 391.553
=	-651

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Change In Receivables Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY

Website

https://www.ramedapharma.com

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. It is engaged in the manufacture and sale of branded generic pharmaceutical products nutraceuticals, cosmeceuticals, food supplements, medical devices, and veterinary products. The firm is engaged in therapeutic areas namely systemic anti-infectives, alimentary tract and metabolism, genitourinary system and sex hormones, cardiovascular system, nervous system, and blood and blood-forming organs.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Headlines

No Headlines